2022
DOI: 10.1016/j.amsu.2022.104143
|View full text |Cite
|
Sign up to set email alerts
|

Scleroderma and interstitial lung disease - A case report

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
1

Citation Types

0
1
0

Year Published

2024
2024
2024
2024

Publication Types

Select...
1

Relationship

0
1

Authors

Journals

citations
Cited by 1 publication
(1 citation statement)
references
References 9 publications
0
1
0
Order By: Relevance
“…It is a connective tissue disease with an unclear aetiology, varying clinical symptoms, a chronic course that frequently progresses, and a tendency to include many organs, including the lungs. About 80% of patients with SSc develop lung fibrosis, and 25% go on to develop progressive interstitial lung disease (ILD), which has a 40% 10-year death rate and is one of the main causes of morbidity and mortality [4].…”
Section: Introductionmentioning
confidence: 99%
“…It is a connective tissue disease with an unclear aetiology, varying clinical symptoms, a chronic course that frequently progresses, and a tendency to include many organs, including the lungs. About 80% of patients with SSc develop lung fibrosis, and 25% go on to develop progressive interstitial lung disease (ILD), which has a 40% 10-year death rate and is one of the main causes of morbidity and mortality [4].…”
Section: Introductionmentioning
confidence: 99%